96 related articles for article (PubMed ID: 9129201)
41. CD26 and CD30 expression on the surface of lymphocyte during normal pregnancy.
Hoshimoto K; Hayashi M; Ohkura T
Gynecol Obstet Invest; 2001; 52(1):9-12. PubMed ID: 11549856
[TBL] [Abstract][Full Text] [Related]
42. Comparative study of CD26 as a Th1-like and CD30 as a potential Th2-like operational marker in leprosy.
Seitzer U; Scheel-Toellner D; Hahn M; Heinemann G; Mattern T; Flad HD; Gerdes J
Adv Exp Med Biol; 1997; 421():217-21. PubMed ID: 9330700
[TBL] [Abstract][Full Text] [Related]
43. Role for CD30 antigen in human T helper 2-type responses.
Romagnani S
Ciba Found Symp; 1995; 195():55-62; discussion 62-7. PubMed ID: 8724830
[TBL] [Abstract][Full Text] [Related]
44. Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 disease.
Kilwinski J; Berger T; Mpalaskas J; Reuter S; Flick W; Kern P
Clin Exp Immunol; 1999 Jan; 115(1):114-9. PubMed ID: 9933429
[TBL] [Abstract][Full Text] [Related]
45. Soluble CD30: a biomarker for evaluating the clinical risk versus benefit of IFNbeta1A treatment in multiple sclerosis patients.
Contasta I; Totaro R; Berghella AM; Pellegrini P; Del Beato T; Carolei A; Adorno D
Int J Immunopathol Pharmacol; 2010; 23(1):213-26. PubMed ID: 20378007
[TBL] [Abstract][Full Text] [Related]
46. Expression and a role of CD30 in regulation of T-cell activity.
Tarkowski M
Curr Opin Hematol; 2003 Jul; 10(4):267-71. PubMed ID: 12799531
[TBL] [Abstract][Full Text] [Related]
47. Circulating levels of soluble CD30 are increased in patients with systemic sclerosis (SSc) and correlate with serological and clinical features of the disease.
Giacomelli R; Cipriani P; Lattanzio R; Di Franco M; Locanto M; Parzanese I; Passacantando A; Ciocci A; Tonietti G
Clin Exp Immunol; 1997 Apr; 108(1):42-6. PubMed ID: 9097909
[TBL] [Abstract][Full Text] [Related]
48. Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis.
Maehara T; Kaneko N; Perugino CA; Mattoo H; Kers J; Allard-Chamard H; Mahajan VS; Liu H; Murphy SJ; Ghebremichael M; Fox D; Payne AS; Lafyatis R; Stone JH; Khanna D; Pillai S
J Clin Invest; 2020 May; 130(5):2451-2464. PubMed ID: 31990684
[TBL] [Abstract][Full Text] [Related]
49. Decline in Total Serum IgE and Soluble CD30 in the Context of Soil-Transmitted Helminth Decline in Bolivia.
Della Bella C; Spinicci M; Rojo D; Grassi A; Gamboa H; Benagiano M; Torrez R; Tapinassi S; Gabrielli S; Cancrini G; Macchioni F; Alnwaisri H; Azzurri A; Monasterio J; Montresor A; Olliaro P; D'Elios MM; Bartoloni A
Am J Trop Med Hyg; 2020 Apr; 102(4):847-850. PubMed ID: 31989919
[TBL] [Abstract][Full Text] [Related]
50. Intrinsic factor recognition promotes T helper 17/T helper 1 autoimmune gastric inflammation in patients with pernicious anemia.
Troilo A; Grassi A; Petrone L; Cianchi F; Benagiano M; Bella CD; Capitani N; Bitetti J; D'Elios S; Tapinassi S; Azzurri A; Alnwaisri H; Romagnoli J; Bizzaro N; Bergman M; Baldari CT; D'Elios MM
Oncotarget; 2019 Apr; 10(30):2921-2929. PubMed ID: 31080562
[TBL] [Abstract][Full Text] [Related]
51. CD30 Is Highly Expressed in Chronic Obstructive Pulmonary Disease and Induces the Pulmonary Vascular Remodeling.
Luo L; Liu Y; Chen D; Chen F; Lan HB; Xie C
Biomed Res Int; 2018; 2018():3261436. PubMed ID: 29984229
[TBL] [Abstract][Full Text] [Related]
52. Concise Commentary: Calling in Your Marker-Rectal CD30-Positive Cells Differentiate Ulcerative Colitis from Crohn's Disease.
Uzzan M
Dig Dis Sci; 2018 Jul; 63(7):1819-1820. PubMed ID: 29721774
[No Abstract] [Full Text] [Related]
53. Skin CD30(+) T cells and circulating levels of soluble CD30 are increased in patients with graft versus host disease.
Amedei A; Pimpinelli N; Grassi A; Bella CD; Niccolai E; Brancati S; Benagiano M; D'Elios S; Bosi A; D'Elios MM
Auto Immun Highlights; 2014 Jun; 5(1):21-6. PubMed ID: 26000151
[TBL] [Abstract][Full Text] [Related]
54. γδ T Lymphocytes Coordinate Eosinophil Influx during Allergic Responses.
de Oliveira Henriques MD; Penido C
Front Pharmacol; 2012; 3():200. PubMed ID: 23316161
[TBL] [Abstract][Full Text] [Related]
55. Safety and efficacy of brentuximab vedotin for Hodgkin lymphoma recurring after allogeneic stem cell transplantation.
Gopal AK; Ramchandren R; O'Connor OA; Berryman RB; Advani RH; Chen R; Smith SE; Cooper M; Rothe A; Matous JV; Grove LE; Zain J
Blood; 2012 Jul; 120(3):560-8. PubMed ID: 22510871
[TBL] [Abstract][Full Text] [Related]
56. Increased serum levels of soluble CD30 in patients with common variable immunodeficiency and its clinical implications.
Rezaei N; Haji-Molla-Hoseini M; Aghamohammadi A; Pourfathollah AA; Moghtadaie M; Pourpak Z
J Clin Immunol; 2008 Jan; 28(1):78-84. PubMed ID: 17912490
[TBL] [Abstract][Full Text] [Related]
57. Maternal serum soluble CD30 is increased in normal pregnancy, but decreased in preeclampsia and small for gestational age pregnancies.
Kusanovic JP; Romero R; Hassan SS; Gotsch F; Edwin S; Chaiworapongsa T; Erez O; Mittal P; Mazaki-Tovi S; Soto E; Than NG; Friel LA; Yoon BH; Espinoza J
J Matern Fetal Neonatal Med; 2007 Dec; 20(12):867-78. PubMed ID: 17853188
[TBL] [Abstract][Full Text] [Related]
58. Early CD30 signaling is critical for adoptively transferred CD4+CD25+ regulatory T cells in prevention of acute graft-versus-host disease.
Zeiser R; Nguyen VH; Hou JZ; Beilhack A; Zambricki E; Buess M; Contag CH; Negrin RS
Blood; 2007 Mar; 109(5):2225-33. PubMed ID: 17068147
[TBL] [Abstract][Full Text] [Related]
59. Deciphering CD30 ligand biology and its role in humoral immunity.
Kennedy MK; Willis CR; Armitage RJ
Immunology; 2006 Jun; 118(2):143-52. PubMed ID: 16771849
[TBL] [Abstract][Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
